Cocrystal Pharma(us:COCP)
2.25
+7.14%
Updated on 2024-12-22
Open:2.12
Close:2.25
High:2.33
Low:2.02
Pre Close:2.10
Volume:64011.00
Amount:139607.23
Turnover:0.63%
Shares:10.17M
MarketCap:22.89M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 17 | 674406 | 6.63% | 1 | 4 | 8 |
| 2024-03-31 | 17 | 721604 | 7.09% | 0 | 7 | 5 |
| 2023-12-31 | 18 | 683350 | 6.72% | 2 | 4 | 5 |
| 2023-09-30 | 20 | 704234 | 6.92% | 0 | 6 | 7 |
| 2023-06-30 | 21 | 666904 | 6.56% | 0 | 4 | 5 |
| 2023-03-31 | 23 | 738898 | 9.07% | 2 | 3 | 6 |
| 2022-12-31 | 29 | 1066183 | 13.09% | 2 | 15 | 11 |
| 2022-09-30 | 37 | 1130727 | 1.16% | 3 | 5 | 15 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 275656 | 2.71% | 0 | |
| 2024-03-31 | Renaissance Technologies Llc | 126028 | 1.24% | 900 | 0.72% |
| 2024-03-31 | Blackrock Inc. | 73746 | 0.72% | -317 | -0.43% |
| 2024-03-31 | Geode Capital Management, Llc | 60432 | 0.59% | 0 | |
| 2024-03-31 | Morgan Stanley | 59271 | 0.58% | -6 | -0.01% |
| 2024-03-31 | Susquehanna International Group, Llp | 52130 | 0.51% | 17586 | 50.91% |
| 2024-03-31 | State Street Corp | 24443 | 0.24% | 0 | |
| 2024-03-31 | Ubs Group Ag | 20258 | 0.20% | 20091 | 12030.54% |
| 2024-03-31 | Northern Trust Corp | 12207 | 0.12% | 0 | |
| 2024-03-31 | Bank Of America Corp /De/ | 8975 | 0.09% | -4 | -0.04% |
About
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.
Address:19805 North Creek Parkway
Website:http://www.cocrystalpharma.com
Market Movers